Frecuencia de síndrome metabólico en niños con obesidad diagnosticado con criterios de IDEFICS
Revista Mexicana de Pediatría · 2021
DOI: 10.35366/103897 ↗At a glance
Journal article in Revista Mexicana de Pediatría, 2021. Written by María de la Cruz Ruiz-Jaramillo and 1 co-authors. 18 references.
Abstract (original language)
Introduction
The European initiative: Identification and prevention of Dietary- and lifestyle-induced health EFects In Children and infantS (IDEFICS) established criteria for the diagnosis of metabolic syndrome (MS) in children younger than 10 years of age.
Objective
To describe the frequency of MS with the IDEFICS criteria in children aged 3 to 10 years with obesity (body mass index ≥ 95th percentile). Material and methods: Descriptive, observational, and retrospective study, carried out between 2017 and 2018 in the Servicio de Pediatría del Hospital General León, Guanajuato, México.
Results
A total of 73 patients were included, of which 53 (72.6%) met three or more IDEFICS criteria, thus being identified with MS. Of the 53 patients, 14 had a monitoring level and 39 had an intervention level. Dyslipidemia and insulin resistance were the most common MS components.
Conclusions
The IDEFICS criteria are useful for identifying children younger than 10 years who have one or more SM components.
Cite
APA
Ruiz-Jaramillo, M. D. L. C., & López-Acevedo, M. (2021). Frecuencia de síndrome metabólico en niños con obesidad diagnosticado con criterios de IDEFICS. Revista Mexicana de Pediatría. https://doi.org/10.35366/103897
Vancouver
Ruiz-Jaramillo MDLC, López-Acevedo M. Frecuencia de síndrome metabólico en niños con obesidad diagnosticado con criterios de IDEFICS. Revista Mexicana de Pediatría. 2021. doi:10.35366/103897
BibTeX
@article{RuizJaramillo2021,
author = {Ruiz-Jaramillo, María de la Cruz and López-Acevedo, Mauricio},
title = {Frecuencia de síndrome metabólico en niños con obesidad diagnosticado con criterios de IDEFICS},
journal = {Revista Mexicana de Pediatría},
year = {2021},
doi = {10.35366/103897}
}
EUVIMED